Remnant lipoproteins as therapeutic targets

Current Opinion in Lipidology

Volumn 11, Issue 6, 2000, Pages 615-620

  Havel, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL ESTER; CHYLOMICRON; LIPOPROTEIN; TRIACYLGLYCEROL; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; HUMAN; HYGIENE; HYPERTRIGLYCERIDEMIA; MACROPHAGE; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ANIMALS; APOLIPOPROTEINS B; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL ESTERS; CHYLOMICRON REMNANTS; CHYLOMICRONS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MACROPHAGES; TRIGLYCERIDES;

EID: 0033669114     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200012000-00008     Document Type: Review

References (63)

1. Triglyceride-rich lipoprotein remnants
2. Atherogenicity of triglyceride-rich lipoproteins
3. Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis
4. Postprandial lipoprotein metabolism and atherosclerosis
5. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat
6. Characterization of human very low density lipoproteins containing two electrophoretic populations: Double pre-beta lipoproteinemia and primary dysbetalipoproteinemia
7. Primary dysbetalipoproteinemia: Predominance of a specific apoprotein species in triglyceride-rich lipoproteins
8. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans
9. Plasma cholesteryl ester transfer protein
10. Apoprotein composition of very low density lipoproteins of human serum
11. Contrasts and similarities between the metabolism of intestinal and hepatic lipoproteins: The role of particle size
12. Lipoprotein clearance mechanisms in LDL receptor-deficient 'Apo-B48-only' and 'Apo-B100-only' mice
13. Chylomicron/chylomicron remnant turnover in humans; evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants
14. Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine
15. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans
16. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
17. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma
18. Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro
19. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans
20. Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans
21. Atherogenesis: A postprandial phenomenon
22. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor
23. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins
24. A macrophage receptor for apolipoprotein B48: Cloning, expression, and atherosclerosis
25. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor
26. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
27. Is atherosclerosis exclusively a postprandial phenomenon?
28. Plasma lipoproteins enhance tissue factor: Independent factor VII activation
29. Plasminogen-activator inhibitor type 1 and coronary artery disease
30. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins
31. Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I
32. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100
33. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
34. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
35. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects
36. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
37. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
38. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia
39. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria
40. High postprandial plasma remnant-like particles: Cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis
41. Association of remnant-like particle cholesterol with coronary artery disease in patients with normal total cholesterol levels
42. Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease
43. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death
44. Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease
45. Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers
46. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
47. Plasma concentrations of remnant lipoproteins are related to intima-media thickness of the common carotid artery independently of LDL cholesterol and plasma triglycerides in healthy middle-aged men
48. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation
49. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries
50. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles
51. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation
52. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
53. Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages
54. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro
55. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial
56. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease
57. Post-prandial lipaemia
58. Differences in postprandial concentrations of very low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary head disease
59. Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease
60. Postprandial hyperlipidemia and remnant lipoproteins
61. Influence of diets rich in saturated and omega-6 polyunsaturated fatty acids on the postprandial responses of apolipoproteins B-48, B-100, E, and lipids in triglyceride-rich lipoproteins
62. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy
63. Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men